Matches in Nanopublications for { <http://bio2rdf.org/drugbank_resource:DB00582_DB06414> ?p ?o ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- drugbank_resource:DB00582_DB06414 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00582_DB06414 label "DDI between Voriconazole and Etravirine - Etravirine, when used concomitantly with variconazole, may experience an increase in serum concentration due to decreased metabolism of etravirine. Voriconazole, when used concomitantly with etravirine (a CYP2C19 inhibitor), may experience a decrease in serum concentration. Monitor for changes in efficacy and toxicity of both agents if concomitant therapy is initiated, modified or discontinued. [drugbank_resource:DB00582_DB06414]" assertion.
- drugbank_resource:DB00582_DB06414 identifier "drugbank_resource:DB00582_DB06414" assertion.
- drugbank_resource:DB00582_DB06414 title "DDI between Voriconazole and Etravirine - Etravirine, when used concomitantly with variconazole, may experience an increase in serum concentration due to decreased metabolism of etravirine. Voriconazole, when used concomitantly with etravirine (a CYP2C19 inhibitor), may experience a decrease in serum concentration. Monitor for changes in efficacy and toxicity of both agents if concomitant therapy is initiated, modified or discontinued." assertion.